- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma Eclipses Insurance As Top Network Radio Advertiser
InsideRadio.com reported pharmaceutical companies have ramped up their advertising on network radio, with drug stores and pharmaceutical firms investing $150.9m in the medium for 2022, according to MillerKaplan.
The pharmaceutical segment accounted for $146.3m, up 14.1% year-over-year, while spending by drug stores plummeted 50.7% to $4.6m.
The rise was driven by companies including Pfizer, which spent $62m on network radio in 2022.
Advancements in targeting and supply-side products have made radio a more efficient channel for pharmaceutical advertisers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
